KIMBERLY BUNCKE: Open Payments
NPI 1912308883 · SOUTH SETAUKET, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,628 in 139 payments from 11 companies in 2025. Trend: 2023 $2,970 · 2024 $2,759 · 2025 $2,628
Food & beverage: $2,628
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 43 | $639 |
| Neurocrine BioSciences, Inc. | 17 | $390 |
| Axsome Therapeutics, Inc. | 14 | $272 |
| Supernus Pharmaceuticals, Inc. | 11 | $243 |
| Otsuka America Pharmaceutical, Inc. | 11 | $236 |
| Lundbeck LLC | 13 | $226 |
| ABBVIE INC. | 11 | $223 |
| Takeda Pharmaceuticals U.S.A., Inc. | 10 | $222 |
| Corium, LLC | 7 | $140 |
| Almatica Pharma LLC | 1 | $18 |
Products named: CAPLYTA, REXULTI, INGREZZA, Auvelity, Qelbree, VRAYLAR, TRINTELLIX, Azstarys.
Industry payments across NY — which companies pay providers there.
